Helicobacter pylori CagA - A potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins

Microbes and Infection

Volumn 5, Issue 2, 2003, Pages 143-150

  Hatakeyama, Masanori ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

CagA; Gab; Gastric carcinoma; Helicobacter pylori; SHP 2

Indexed keywords

ADAPTOR PROTEIN; CAGA PROTEIN; DOCKING PROTEIN; GROWTH FACTOR; ONCOPROTEIN; PHOSPHATASE; PROTEIN GAB; TYROSINE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

CELL MEMBRANE; EPITHELIUM CELL; HELICOBACTER PYLORI; HUMAN; MAMMAL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; STOMACH EPITHELIUM;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI; MAMMALIA;

EID: 0037295501     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00085-0     Document Type: Review

References (67)

1. Warren J.R., Marshall B.J. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. i:1983;1273-1275.
2. Covacci A., Telford J.L., Giudice G.D., Parsonnet J., Rappuoli R. Helicobacter pylori virulence and genetic geography. Science. 284:1999;1328-1333.
3. Forman D., Newell D.G., Fullerton F., Yarnell J.W., Stacy A.R., Wald N., Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence form a prospective investigation. Br. Med. J. 302:1991;1302-1305.
4. Parsonnet J., Friedman G.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N., Sibley R.K. Helicobacter pylori and the risk of gastric carcinoma. N. Engl. J. M. 325:1991;1127-1131.
5. Nomura A., Stemmermann G.N., Chyou P.H., Kato I., Perez G.I., Blaser M.J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. M. 325:1991;1132-1136.
6. Watanabe T., Tada M., Nagai H., Sasaki S., Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology. 115:1998;642-648.
7. Honda S., Fujioka T., Tokieda M., Satoh R., Nishizono A., Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res. 58:1998;4255-4259.
8. Stolte M., Bayerdorffer E., Morgner A., Alpen B., Wundisch T., Thiede C., Neubauer A. Helicobacter and gastric MALT lymphoma. Gut. 50:(Suppl. III):2002;19-24.
9. Covacci A., Censini S., Bugnoli M., Petracca R., Burroni D., Macchia G., Massone A., Papini E., Xiang Z., Fugura N., Rappuoli R. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA. 90:1993;5791-5795.
10. Tummuru M.K., Cover T.L., Blaser M.J. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immun. 61:1993;1799-1809.
11. Censini S., Lange C., Xiang Z., Crabtree J.E., Ghiara P., Borodovsky M., Rappuoli R., Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA. 93:1996;14648-14653.
12. Akopyants N.S., Clifton S.W., Kersulyte D., Crabtree J.E., Youree B.E., Reece C.A., Bukanov N.O., Drazek E.S., Roe B.A., Berg D.E. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol. Microbiol. 28:1998;37-53.
13. Kuipers E.J., Perez-Perez G.I., Meuwissen S.G., Blaser M.J. Helicobacter pylori and atrophic gastritis. Importance of the cagA status. J. Natl. Cancer Inst. 87:1995;1777-1780.
14. Crabtree J.E., Taylor J.D., Wyatt J.I., Heatley R.V., Shallcross T.M., Tompkins D.S., Rathbone B.J. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet. 338:1991;332-335.
15. Blaser M.J., Perez-Perez G.I., Kleanthous H., Cover T.L., Peek R.M., Chyou P.H., Stemmermann G.N., Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:1995;2111-2115.
16. Personnet J., Friedman G.D., Orentreich N., Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 40:1997;297-301.
17. Rugge M., Busatto G., Cassaro M., Shiao Y.H., Russo V., Leandro G., Avellini C., Fabiano A., Sidoni A., Covacci A. Patients younger than 40 years with gastric carcinoma-Helicobacter pylori genotype and associated gastritis phenotype. Cancer. 85:1999;2506-2511.
18. Rudi J., Kolb C., Maiwald M., Zuna I., vov Herbay A., Galle P.R., Stremmel W. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig. Dis. Sci. 42:1997;1652-1659.
19. +Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico. Int. J. Cancer. 78:1998;298-300.
20. Shimoyama T., Fukuda S., Tanaka M., Mikami T., Munakata A., Crabtree J.E. CagA seropositivity associated with development of gastric cancer in a Japanese population. J. Clin. Pathol. 51:1998;225-228.
21. Nomura M., Lee J., Stemmermann G.N., Nomura R.Y., Perez-Perez G.I., Blaser M.J. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J. Infect. Dis. 186:2002;1138-1144.
22. Kikuchi S., Crabtree J.E., Forman D., Kurosawa M. Association between infections with CagA-positive or - negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Am. J. Gastroenterol. 94:1999;3455-3459.
23. Kodama K., Ito A., Nishizono A., Fujioka T., Nasu M., Yahiro K., Hirayama T., Uemura N. Divergence of virulence factors of Helicobacter pylori among clinical isolates does not correlate with disease specificity. J. Gastroenterol. 34:(Suppl. 11):1999;6-9.
24. Kikuchi S. Epidemiology of Helicobacter pylori and gastric cancer. Gastric Cancer. 5:2002;6-15.
25. Enroth H., Kraaz W., Rohan T., Nyren O., Engstrand L. Does the method of Helicobacter pylori detection influence the association with gastric cancer risk? Scand. J. Gastroenterol. 37:2002;884-890.
26. Yamaoka Y., Kodama T., Kashima K., Graham D.Y., Sepulveda A.R. Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J. Clin. Microbiol. 36:1998;2258-2263.
27. Yamaoka Y., El-Zimaity H.M., Gutierrez O., Figura N., Kim J.G., Kodama T., Kashima K., Graham D.Y., Kim J.K. Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology. 117:1999;342-349.
28. Segal E.D., Cha J., Lo J., Falkow S., Tompkins L.S. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. USA. 96:1999;14559-14564.
29. Asahi M., Azuma T., Ito S., Ito Y., Suto H., Nagai Y., Tsubokawa M., Tohyama Y., Maeda S., Omata M., Suzuki T., Sasakawa C. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. M. 191:2000;593-602.
30. Stein M., Rappuoli R., Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc. Natl. Acad. Sci. USA. 97:2000;1263-1268.
31. Odenbreit S., Puls J., Sedlmaier B., Gerland E., Fischer W., Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science. 287:2000;1497-1500.
32. Backert S., Ziska E., Brinkmann V., Zimny-Arndt U., Fauconnier A., Jungblut P.R., Naumann M., Meyer T.F. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol. 2:2000;155-164.
33. Fischer W., Puls J., Buhrdorf R., Gebert B., Odenbreit S., Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42:2001;1337-1348.
34. Higashi H., Tsutsumi R., Muto S., Sugiyama T., Azuma T., Asaka M., Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 295:2002;683-686.
35. Stein M., Bagnoli F., Halenbeck R., Rappuoli R., Fantl W.J., Covacci A. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol. 43:2002;971-980.
36. Backert S., Moese S., Selbach M., Brinkmann V., Meyer T.F. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol. Microbiol. 42:2001;631-644.
37. Higashi H., Tsutsumi R., Fujita A., Yamazaki S., Asaka M., Azuma T., Hatakeyama M. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. USA. 99:2002;14428-14433.
38. Selbach M., Moese S., Hauck C.R., Meyer T.F., Backert S. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J. Biol. Chem. 277:2002;6775-6778.
39. Puls J., Fischer W., Haas R. Activation of Helicobacter pylori CagA by tyrosine phosphorylation is essential for dephosphorylation of host cell proteins in gastric epithelial cells. Mol. Micorbiol. 43:2002;961-969.
40. Kodama A., Matozaki T., Fukuhara A., Kikyo M., Ichihashi M., Takai Y. Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering. Mol. Biol. Cell. 11:2000;2565-2575.
41. Neel B.G. Structure and function of SH2-domain containing tyrosine phosphatases. Semin. Cell Biol. 6:1993;419-432.
42. Feng G.S., Pawson T. Phosphotyrosine phosphatases with SH2 domains: regulators of signal transduction. Trends Genet. 10:1994;54-58.
43. Songyang Z., Shoelson S.E., Chaudhuri M., Gish G., Pawson T., Haser W.G., King F., Roberts T., Ratnofsky S., Lechleider R.J. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767-778.
44. De Souza D., Fabri L.J., Nash A., Hilton D.J., Nicola N.A., Baca M. SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatases SHP-2 have similar binding specificities. Biochemistry. 41:2002;9229-9236.
45. Hof P., Pluskey S., Dhe-Paganon S., Ech M.J., Shoelson S.E. Crystal structure of the tyrosine phosphatase SHP-2. Cell. 92:1998;441-450.
46. Zhang J., Somani A.K., Siminovitch K.A. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin. Immunol. 12:2000;361-378.
47. Van Vactor D., O'Reilly A.M., Neel B.G. Genetic analysis of protein tyrosine phosphatases. Curr. Opin. Genet. Dev. 8:1998;112-126.
48. Perkins L.A., Larsen I., Perrimon N. corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso. Cell. 70:1992;225-236.
49. Perkins L.A., Johnson M.R., Melnick M.B., Perrimon N. The non-receptor protein tyrosine phosphatase Corkscrew functions in multiple receptor tyrosine kinase pathways in Drosophila. Dev. Biol. 180:1996;63-81.
50. Maroun A.R., Naujokas M.A., Holgado-Madruga M., Wong A.J., Park M. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol. Cell. Biol. 20:2000;8513-8525.
51. Yu H., Qu C.K., Henegariu O., Lu X., Feng G.S. Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J. Biol. Chem. 273:1998;21125-21131.
52. Manes S., Mira E., Gomez-mouton C., Zhao Z.J., Lacalle R.A., Martinez-A C. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol. Cell. Biol. 19:1999;3125-3135.
53. Oh S., Gu H., Saxton T.M., Timma J.F., Hausdorff S., Frevert E.U., Kahn B.B., Pawson T., Neel B.G., Thomas S.M. Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2. Mol. Cell. Biol. 19:1999;3205-3215.
54. Schoenwaelder S.M., Petchi L.A., Williamson D., Shen R., Feng G.S., Burridge K. The protein tyrosine phosphatase Shp-2 regulates RhoA activity. Current Biol. 10:2000;1523-1526.
55. Kodama A., Matozaki T., Shinohara M., Fukuhara A., Tachibana K., Ichihashi M., Nakanishi H., Takai Y. Regulation of Ras and Rho small G proteins by SHP-2. Genes Cells. 6:2001;869-876.
56. Caron E. Regulation of Wiscott-Aldrich syndrome protein and related molecules. Curr. Opin. Cell Biol. 14:2000;82-87.
57. Higgs N., Pollard T.D. Regulation of actin filament network formation through ARP2/3 complex: activation by a diverse array of proteins. Annu. Rev. Biochem. 70:2001;649-676.
58. Lock L.S., Royal I., Naujokas M.A., Park M. Identification of an atypical Grb2 carboxy-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and independent recruitment of Gab1 to receptor tyrosine kinases. J. Biol. Chem. 275:2000;31536-31545.
59. Liu Y., Rohrschneider L.R. The gift of Gab. FEBS Lett. 515:2002;1-7.
60. Schaeper U., Gehring N.H., Fuchs K.P., Sachs M., Kempkes B., Birchmeier W. Coupling of Gab1 to c-Met. Grb2, and SHP2 mediates biological responses. J. Cell Biol. 149:2000;1419-1432.
61. Hunter T. Oncoprotein networks. Cell. 88:1997;333-346.
62. Evan I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.
63. Mayo M.W., Wang C.Y., Cogswell P.C., Rogers-Graham K.S., Lowe S.W., Der C.J., Baldwin Jr A.S. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science. 278:1997;1812-1815.
64. Anti M., Armuzzi A., Gasbarrini A., Gasbarrini G. Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis. Gut. 43:(Suppl. I):1998;27-32.
65. Sherr J. Cancer cell cycles. Science. 274:1996;1672-1677.
66. Daly R.J., Gu H., Parmar J., Malaney S., Lyons R.J., Kairouz R., Head D.R., Henshall S.M., Neel B.G., Sutherland R.L. The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer. Oncogene. 21:2002;5175-5181.
67. Alm R.A., Ling L.S., Moir D.T., King B.L., Brown E.D., Doig P.C., Smith D.R., Noonan B., Guild B.C., deJonge B.L., Carmel G., Tummino P.J., Caruso A., Uria-Nickelsen M., Mills D.M., Ives C., Gibson R., Merberg D., Mills S.D., Jiang Q., Taylor D.E., Vovis G.F., Trust T.J. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 397:1999;76-80.